| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 04/27/2006 | CA2583454A1 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | CA2578300A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 04/26/2006 | EP1650200A1 Sulfonate compound and fluorescent probe using the same |
| 04/26/2006 | CN1764448A A protectant of periodontal membranes |
| 04/26/2006 | CN1763209A Comprehensive utilization process for gingko episperm |
| 04/26/2006 | CN1763031A Method for extracting soybean isoflavone from soybean whey liquid |
| 04/26/2006 | CN1763030A Puerarin derivatives and their medical uses |
| 04/26/2006 | CN1763029A Method for separating rubescensinA from rabdosia |
| 04/26/2006 | CN1253447C Method for fixed bed transfer of natural vitamin E |
| 04/26/2006 | CN1253446C Method for preparing high content proanthocyanidin |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/20/2006 | WO2006041888A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents |
| 04/20/2006 | WO2006040676A1 Nitrosated benzopyran compounds as novel cyclooxygenase-2 selective inhibitors |
| 04/20/2006 | WO2006040672A1 Substituted cyclopropyl chromene compounds for use in the treatment and prevention of inflammation related conditions |
| 04/20/2006 | WO2006040178A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040009A2 Chroman derivatives and use thereof in liquid crystal media |
| 04/20/2006 | US20060084698 Methods for preparation and use of psorospermin analogs |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | DE102005045849A1 Preparation of benzocondensed oxyheterocycle, useful in liquid crystalline mixtures, comprises regioselective opening of e.g. oxetane by metallized fluoroaromates and cyclizing the obtained propanol derivative by non-nucleophilic base |
| 04/20/2006 | CA2584709A1 Oxy substituted flavones as antihyperglycemic and antidyslipidemic agents |
| 04/20/2006 | CA2582459A1 Substituted sulfones and methods of use |
| 04/19/2006 | EP1646627A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |
| 04/19/2006 | CN1761668A 7-imino derivatives of camptothecin having antitumor activity |
| 04/19/2006 | CN1761660A Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles |
| 04/19/2006 | CN1760195A Method for separating and purifying 9-nitro camptothecin |
| 04/19/2006 | CN1760194A Method for synthesizing 3-(5'-substitution-2-benzoxazole group)-7-diethyl amino group H-1-benzopyrans-2-ketone |
| 04/19/2006 | CN1252073C Process for preparation of garcinia acid |
| 04/19/2006 | CN1252062C Prepn of high-content vitamin E |
| 04/19/2006 | CN1251692C Strain of microorganism able to metabolizing daidzein to equol and its prodn. method for equol by using such strain of microorganism |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/14/2006 | WO2005032544A1 Treatment of mitochondrial diseases |
| 04/14/2006 | CA2580584A1 Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| 04/13/2006 | WO2006038656A1 Allergy suppressant |
| 04/13/2006 | WO2006037996A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 04/13/2006 | WO2006016167A3 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc. |
| 04/13/2006 | WO2005051844A3 Processes for preparing salts of alcohol polybasic acid partial esters using metal oxides, metal hydroxides and/or metal carbonates |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | DE102005045848A1 New chromane and chromene derivatives useful as components in liquid crystalline media and in liquid crystal display element or electrooptical display element |
| 04/13/2006 | CA2582294A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 04/13/2006 | CA2580221A1 Novel cyclic and acyclic propenones for treating cns disorders |
| 04/12/2006 | EP1644311A2 Enantioselective synthesis of enantiomerically enriched compounds |
| 04/12/2006 | EP1032555B1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 04/12/2006 | CN1757642A Method for preparing soyabean dregs isoflavone |
| 04/12/2006 | CN1250561C Method for extracting kudzu vine root total flavone |
| 04/12/2006 | CN1250537C Method for treating product stream containing vitamin E acetate |
| 04/12/2006 | CN1250536C 4-aminobenzopyran derivatives |
| 04/12/2006 | CN1250289C Drugs, drinks or foods |
| 04/11/2006 | USRE39061 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026314 Psychological disorders, antidepressants, anxiolytic agents, eating disorders; serotonin receptors antagonist |
| 04/06/2006 | WO2006035897A1 Composition inhibiting sex hormone-binding globulin |
| 04/06/2006 | WO2006015811A3 Technically produced dihydrocoumarin |
| 04/06/2006 | US20060074252 Synthetic route to dronabinol |
| 04/06/2006 | US20060074127 anticancer agents; chemotherapeutic selective agents |
| 04/06/2006 | US20060074126 Chroman derivatives, medicaments and use in therapy |
| 04/06/2006 | US20060073223 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 04/06/2006 | DE102004045220A1 Neue Arzneimittel New drugs |
| 04/05/2006 | EP1642895A2 Novel substituted naphthopyrans |
| 04/05/2006 | EP1641772A1 Manufacture of tocopherols using a bismuth catalyst |
| 04/05/2006 | EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 04/05/2006 | EP1333805B1 Cosmetic method of treating skin |
| 04/05/2006 | CN1756750A Adiponectin expression promoter |
| 04/05/2006 | CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 04/05/2006 | CN1754881A Chemical synthetic process of D-fluorescein and device therefor |
| 04/05/2006 | CN1754553A Use of erythrina and its isoflavone analog compound in medicine for osteoporosis |
| 04/05/2006 | CN1249045C Process for the preparation of isoflavones |
| 04/05/2006 | CN1249044C Chromanone derivatives |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 04/04/2006 | US7022640 1,3-diethers and components and catalysts for the polymerization of olefins, containing said diethers |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006032120A2 Substituted cumarines, process for the production of said cumarines and composition containing said cumarines |
| 03/30/2006 | WO2006032086A1 Chroman derivatives, medicaments and use in therapy |
| 03/30/2006 | WO2006032085A1 Substituted chroman derivatives, medicaments and use in therapy |
| 03/30/2006 | US20060069046 Green tea extract ; for use in foods and supplements |
| 03/30/2006 | US20060068042 Method for producing composition containing soluble isoflavones |
| 03/30/2006 | CA2581316A1 Substituted chroman derivatives, medicaments and use in therapy |
| 03/29/2006 | EP1640371A1 Flavanone compound and uses thereof |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 03/29/2006 | CN1752082A Gallate catechin and its preparation method |
| 03/29/2006 | CN1752081A Method of extracting licorice flavone from licorice slag |
| 03/29/2006 | CN1247592C Optics decomposing method for coumarin dimer |
| 03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 03/29/2006 | CN1247509C Method for producing chroman |
| 03/28/2006 | US7019149 Thromboxane ligands without blood clotting side effects |
| 03/28/2006 | US7019104 Diamine novel acid dianhydride and novel polyimide composition formed therefrom |
| 03/28/2006 | US7019094 Intermediate products, methods for their preparation and use thereof |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7018431 Useful as fluorescent labels of nucleosides, nucleotides, polynucleotides, and polypeptides. |
| 03/23/2006 | WO2006030609A1 Lactone compound, lactone-containing monomer, polymer of those, resist composition using same, method for forming pattern using same |
| 03/23/2006 | WO2006030208A1 Amino acid |
| 03/23/2006 | WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols |
| 03/23/2006 | WO2006029532A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | US20060063953 Process for the preparation of nitroalkenes |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063806 4-(4,5,6-trimethoxy-2-benzaldehyde) coumarin; fungicides, nontoxic |
| 03/23/2006 | US20060063769 Preventives/remedies for urinary disturbance |
| 03/23/2006 | US20060063734 4,7-dichlorofluorescein dyes as molecular probes |
| 03/23/2006 | US20060063034 Organic electroluminescent material and organic electroluminescent device by using the same |